Social anxiety disorder is one of the most persistent and common of the anxiety disorders, with lifetime prevalence rates in Europe of 6.7% (range 3.9-13.7%).
1 It often coexists with depression, substance use disorder, generalised anxiety disorder, panic disorder, and post-traumatic stress disorder. 2 It can severely impair a person's daily functioning by impeding the formation of relationships, reducing quality of life, and negatively affecting performance at work or school. Despite this, and the fact that effective treatments exist, only about half of people with this condition seek treatment, many after waiting 10-15 years. 3 Although about 40% of those who develop the condition in childhood or adolescence recover before adulthood, 4 for many the disorder persists into adulthood, with the chance of spontaneous recovery then limited compared with other mental health problems.
This article summarises the most recent recommendations from the National Institute for Health and Care Excellence (NICE) on recognising, assessing, and treating social anxiety disorder in children, young people, and adults. 5 
Recommendations
NICE recommendations are based on systematic reviews of the best available evidence and explicit consideration of cost effectiveness. When minimal evidence is available, recommendations are based on the Guideline Development Group's experience and opinion of what constitutes good practice. Evidence levels for the recommendations are given in italic in square brackets.
Principles for working with all people with social anxiety disorder
• When a person is first offered an appointment, provide clear information in a letter about: -Where to go on arrival and where they can wait (offer the use of a private waiting area or the option to wait elsewhere-for example, outside the service's premises) about their feelings of anxiety, fear, avoidance, distress, and associated behaviours, to help establish if social anxiety disorder is present, using the following statement and questions: "Sometimes people get very scared when they have to do things with other people, especially people they don't know. They might worry about doing things with other people watching. They might get scared that they will do something silly or that people will make fun of them. They might not want to do these things or, if they have to do them, they might get very upset or cross." Then ask: -"Do you/does your child get scared about doing things with other people, like talking, eating, going to parties, or other things at school or with friends?" -"Do you/does your child find it difficult to do things when other people are watching, like playing sport, being in plays or concerts, asking or answering questions, reading aloud, or giving talks in class?"
-"Do you/does your child ever feel that you/your child can't do these things or tries to get out of them?"
[Based on the experience and opinion of the GDG]
If the child or young person or parents or carers answer "yes" to one or more of the questions consider a comprehensive assessment for social anxiety disorder. The components of the recommended psychological therapies for adults can be found in the full NICE guideline.
5
Interventions for children and young people with social anxiety disorder
• Offer individual or group CBT focused on social anxiety. Consider involving parents or carers for effective delivery of the intervention, particularly in young children.
[Based on a systematic review and meta-analysis]
The components of the recommended psychological therapies for adults can be found in the full NICE guideline. 
Overcoming barriers
The guideline deals with several potential barriers to people seeking treatment for social anxiety disorder: people may think that the social anxiety is part of their personality and cannot be changed (or, in the case of children, that they will grow out of it); they may fear negative evaluation by healthcare professionals if they disclose their problem; even after presentation, the disorder may not be recognised by healthcare professionals, especially in primary care. 10 The guideline advises healthcare professionals to be aware of barriers to people seeking treatment, and on how to identify the disorder in all age groups and how services can make themselves more accessible. It also recommends effective treatments and seeks to help commissioners identify the services that should be made available.
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Further information on the guidance
Factors prompting the development of this guideline include the poor recognition and inadequate assessment of social anxiety disorder and the limited awareness or availability of treatments despite the existence of effective psychological and drug interventions. Social anxiety disorder is under-recognised in primary care, 10 particularly when it coexists with depression. Often the depressive episode may be identified but the underlying and more persistent social anxiety disorder is not. The early age of onset means that recognition of social anxiety disorder in educational settings is important and may bring early and lasting benefits to children, but it is challenging to achieve this without accurate identification and clear referral pathways.
Methods
This guideline was developed by the National Collaborating Centre for Mental Health using NICE guideline methods (www.nice.org.uk/ guidelinesmanual). The guideline review process involved comprehensive and systematic literature searches to identify relevant evidence for the clinical and economic reviews, with critical appraisal of the quality of the identified evidence. Results of intervention studies were compared using pairwise and network meta-analysis. Results of the network meta-analysis were used to inform an economic model. A multidisciplinary team of healthcare professionals from psychiatry, psychology, and general practice and service user and carer representatives (forming the GDG) was established to review the evidence and develop the subsequent recommendations. The guideline then went through an external consultation with stakeholders. The GDG considered the stakeholders' comments, reanalysed the data where necessary, and modified the guideline as appropriate.
NICE has produced three different versions of the guideline: a full version; a summary version known as the "NICE guideline"; and a version for children, young people, and adults with social anxiety disorder, their parents and carers, and the public. All these versions, as well as a pathway, are available from the NICE website. Updates of the guideline will be produced as part of NICE's guideline development programme.
Areas for future research
• What methods are effective in improving uptake of and engagement with interventions for adults with social anxiety disorder?
• What is the best way of involving parents in the treatment of children and young people with social anxiety disorder at different stages of development?
• What is the clinical and cost effectiveness of specific CBT for children and young people with social anxiety disorder compared with generic anxiety focused CBT?
• What is the clinical and cost effectiveness of individual and group CBT for children and young people with social anxiety disorder?
• What is the clinical and cost effectiveness of combined psychological and drug interventions compared with either intervention alone in treating adults with social anxiety disorder?
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